» Articles » PMID: 24959423

Morphologic and Molecular Evaluation of Chlamydia Trachomatis Growth in Human Endocervix Reveals Distinct Growth Patterns

Abstract

In vitro models of Chlamydia trachomatis growth have long been studied to predict growth in vivo. Alternative or persistent growth modes in vitro have been shown to occur under the influence of numerous stressors but have not been studied in vivo. Here, we report the development of methods for sampling human infections from the endocervix in a manner that permits a multifaceted analysis of the bacteria, host and the endocervical environment. Our approach permits evaluating total bacterial load, transcriptional patterns, morphology by immunofluorescence and electron microscopy, and levels of cytokines and nutrients in the infection microenvironment. By applying this approach to two pilot patients with disparate infections, we have determined that their contrasting growth patterns correlate with strikingly distinct transcriptional biomarkers, and are associated with differences in local levels of IFNγ. Our multifaceted approach will be useful to dissect infections in the human host and be useful in identifying patients at risk for chronic disease. Importantly, the molecular and morphological analyses described here indicate that persistent growth forms can be isolated from the human endocervix when the infection microenvironment resembles the in vitro model of IFNγ-induced persistence.

Citing Articles

Recognition of by Toll-like receptor 9 is altered during persistence.

Diallo A, Overman G, Sah P, Liechti G Infect Immun. 2024; 92(7):e0006324.

PMID: 38899879 PMC: 11238561. DOI: 10.1128/iai.00063-24.


The MraY Inhibitor Muraymycin D2 and Its Derivatives Induce Enlarged Cells in Obligate Intracellular and and Break the Persistence Phenotype in .

Lockener I, Behrmann L, Reuter J, Schiefer A, Klockner A, Krannich S Antibiotics (Basel). 2024; 13(5).

PMID: 38786149 PMC: 11117252. DOI: 10.3390/antibiotics13050421.


Metabolic dormancy in treated with different antibiotics.

Rockey D, Wang X, Debrine A, Grieshaber N, Grieshaber S Infect Immun. 2024; 92(2):e0033923.

PMID: 38214508 PMC: 10863404. DOI: 10.1128/iai.00339-23.


Association of burden with the vaginal microbiota, bacterial vaginosis, and metronidazole treatment.

Ardizzone C, Taylor C, Toh E, Lillis R, Elnaggar J, Lammons J Front Cell Infect Microbiol. 2023; 13:1289449.

PMID: 38149008 PMC: 10750252. DOI: 10.3389/fcimb.2023.1289449.


Identification of the alternative sigma factor regulons of using multiplexed CRISPR interference.

Hatch N, Ouellette S mSphere. 2023; 8(5):e0039123.

PMID: 37747235 PMC: 10597470. DOI: 10.1128/msphere.00391-23.


References
1.
Sutton M, Sternberg M, Koumans E, McQuillan G, Berman S, Markowitz L . The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004. Clin Infect Dis. 2007; 45(10):1319-26. DOI: 10.1086/522532. View

2.
Alzhanov D, Weeks S, Burnett J, Rockey D . Cytokinesis is blocked in mammalian cells transfected with Chlamydia trachomatis gene CT223. BMC Microbiol. 2009; 9:2. PMC: 2657910. DOI: 10.1186/1471-2180-9-2. View

3.
Byrne G, Ouellette S, Wang Z, Rao J, Lu L, Beatty W . Chlamydia pneumoniae expresses genes required for DNA replication but not cytokinesis during persistent infection of HEp-2 cells. Infect Immun. 2001; 69(9):5423-9. PMC: 98653. DOI: 10.1128/IAI.69.9.5423-5429.2001. View

4.
Morre S, van den Brule A, Rozendaal L, Boeke A, Voorhorst F, de Blok S . The natural course of asymptomatic Chlamydia trachomatis infections: 45% clearance and no development of clinical PID after one-year follow-up. Int J STD AIDS. 2003; 13 Suppl 2:12-8. DOI: 10.1258/095646202762226092. View

5.
Zhang L, Howe M, Hatch T . Characterization of in vitro DNA binding sites of the EUO protein of Chlamydia psittaci. Infect Immun. 2000; 68(3):1337-49. PMC: 97287. DOI: 10.1128/IAI.68.3.1337-1349.2000. View